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In response to the COVID-19 pandemic, many governments have taken drastic measures to
avoid an overflow of intensive care units. Accurate metrics of disease spread are critical for
the reopening strategies. Here, we show that self-reports of smell/taste changes are more
closely associated with hospital overload and are earlier markers of the spread of infection of
SARS-CoV-2 than current governmental indicators. We also report a decrease in self-reports
of new onset smell/taste changes as early as 5 days after lockdown enforcement. Cross-
country comparisons demonstrate that countries that adopted the most stringent lockdown
measures had faster declines in new reports of smell/taste changes following lockdown than
a country that adopted less stringent lockdown measures. We propose that an increase in the
incidence of sudden smell and taste change in the general population may be used as an
indicator of COVID-19 spread in the population.
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Following similar decisions in China and Italy, a strict lock-down was enforced in France beginning on March 17, 2020to block the progression of COVID-19 and alleviate pressure
on hospitals. One issue currently faced by governments is how to
conduct the progressive relaxation of the lockdown1, which needs
to be conducted systematically and carefully to prevent sub-
sequent outbreaks while facilitating economic activity and
recovery. On May 7, 2020, the French government categorized
each geographical area as being red or green, depending on their
COVID-19 prevalence. Compared to green areas, red areas were
characterized by: (i) higher active circulation of the virus, (ii)
higher level of pressure on hospitals (i.e., CCRU occupancy), and
(iii) reduced capacity to test new cases (Fig. 1a). In each area, red/
green labels were used to define steps associated with the local
relaxation of lockdown. The French Ministry of Health used the
ratio of consultations for suspected cases of COVID-19 to general
consultations at the emergency room (ER) in hospitals as an
indicator to assess the active circulation of the virus (detailed in
“Methods” section). Concurrently, changes in smell and taste are
prominent symptoms of COVID-192–5, as has consistently. been
demonstrated in many countries (e.g., Iran6, Spain7, France8,
Italy9, Germany10, and the UK2, among others). More critically,
these chemosensory changes generally occur earlier than other
symptoms9 and may constitute more specific symptoms than
fever or dry cough2,11. Accordingly, monitoring self-reported
changes in smell and taste could thus provide early and specific
information on the spread of COVID-19 in the general popula-
tion and support health system monitoring to avoid daily CCRU
admission overflows. Using data from a global, crowd-sourced
study deployed in 30+ languages (Global Consortium for Che-
mosensory Research survey, GCCR, see “Methods” section), we
tested whether changes in smell/taste at the population level could
be used as an early indicator for local COVID-19 outbreaks. As
pre-registered (see “Methods” section), our primary aim was to
test the association between self-reported smell and taste changes
and indicators of pressure in hospitals (COVID-related hospita-
lizations, CCRU admissions, and mortality rates) for each French
administrative region over the last 3 months. Our secondary aim
was to examine temporal relationships between the peak of smell
and taste changes in the population and the peak of COVID-19
cases and the application of lockdown measures. The potential for
self-reported smell and taste loss to serve as an early indicator of
the number of COVID-19 cases—and hence hospital stress—was
tested in a natural experiment by comparing France with Italy
and the UK, which implemented lockdown with different timing
and levels of stringency. Here, we show that self-reports of smell/
taste changes are closely associated with hospital overload and are
early markers of the spread of infection of SARS-CoV-2.
Results
Changes in smell and taste are associated with overwhelmed
healthcare systems. The relationship between self-reported
changes in smell and taste by French residents (diagnosed as
COVID-19+ or not, see “Methods” section and Supplementary
Table 1) and estimators of local healthcare system stress was
evaluated geographically. Figure 1a depicts the geographical dis-
tribution in red and green regions (as defined by the French
government) and participants who self-reported changes in their
smell and taste. Red areas of France account for 40.8% of the
population. Green areas are clustered into a group with both a
low number of self-reported chemosensory changes and a low
number of admissions to CCRUs (Fig. 1b). Red areas show an
opposite trend (Chi-square <1 × 10−200 and Biserial correlations
p < 1.3 × 10−2). A strong relationship exists between self-reported
changes in smell and taste and the number of admissions to
CCRUs (Rsmell= 0.88, p= 8.9 × 10−08). This correlation
remained significant even after removing the two most impacted
areas (Alsace and Ile de France, Rsmell= 0.72; p < 3 × 10−04),
indicating that the significant relationship is not driven solely by
these two regions.
Strikingly, use of self-reported chemosensory changes pro-
duced a stronger correlation than the current governmental
indicator of virus circulation (Fig. 1c). Overall, smell/taste
changes are better correlated with the number of COVID-19
admissions to hospitals than the current governmental indicator
i.e., the ratio of ER consultations for suspicion of COVID-19
to general ER consultations (Rsmell= 0.81, p= 6.71 × 10−06 vs.
Rgov= 0.60, p= 3.35 × 10−03); the same pattern was found for
the number of COVID-19 related deaths (Rsmell= 0.75, p=
5.62 × 10−05 vs. Rgov= 0.58, p= 4.97 × 10−03 see Supplementary
Table 2). Further, when smaller geographical areas were
considered (France is divided into 96 administrative units, called
departments), these correlations remained highly significant (e.g.,
admissions to CCRUs: Rsmell= 0.76, p < 5 × 10−19) (Fig. 1c).
Moreover, the three relationships (change in smell/taste versus
COVID-19-related hospitalization, resuscitations, and death) also
remained highly significant when considering only individuals
who were not clinically diagnosed by a medical professional but
considering themself showing some symptoms of COVID-19
(e.g., admissions to CCRUs: Rsmell= 0.83, p= 1.65 × 10−06).
Potential sampling bias due to regional media coverage of our
survey (Supplementary Table 3) and self-reported chemosensory
changes by region was ruled out by confirming these variables
were not correlated (R < 0.01, p > 0.9).
Notably, relationships between pandemic markers and online
searches related to chemosensation were also significant in
France. Google queries related to smell or taste loss (“perte
odorat,” “perte goût” in French) were correlated with the three
measures of an overwhelmed healthcare system described above
(e.g., CCRU admissions: Rsmell= 0.8, p < 4 × 10−03, see Supple-
mentary Table 2).
Changes in smell and taste are early markers of the effective-
ness of political decisions. Next, we examined the temporal
dynamics in France of self-reported changes in smell/taste, the
current governmental indicator (ratio of ER consults), and the
number of CCRU admissions due to COVID-19 before and after
the lockdown period. As shown in Fig. 1d, the peak of the onset of
changes in smell/taste appeared 4 days after the lockdown and for
these individuals, the first reported COVID-19 symptoms occur
even earlier. Conversely, the governmental indicator of ER consults
only peaked 11 days after the lockdown, while the peak of CCRU
admissions was shifted later by 14 days. This is consistent with
emerging data showing that COVID-19-related changes in smell
and taste occur in the first few days after infection6,12–14. The
robustness of smell and taste changes over time was assessed in two
ways. First, we showed the peak of smell/taste changes remained the
same regardless of our survey’s completion date (Supplementary
Fig. 1a). Second, we observed the exact same peak when analyzing a
separate French survey performed on 950 individuals and focusing
on smell alterations in the French population independently of
COVID-19 (see “Methods” section): the peak of olfactory changes
again occurred 4 days after the lockdown decision, and this was
independent of survey completion dates (Supplementary Fig. 1B).
The robustness of smell and taste changes was also observed over
age (Supplementary Fig. 2A) and gender (Supplementary Fig. 2B).
Finally, we also show that the observed peak does not correspond to
seasonal occurrence of allergies in France based on the ratio of
consultations for Allergy to general consultations at the emergency
room (Supplementary Fig. 3).
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Further, analyses of Google searches confirm this temporal
relationship: on the same days where survey participants report
experiencing their first symptoms (around March 18, 2020), there
was a peak of Google queries for terms associated with early
COVID-19 symptoms (fever, cough, aches, Supplementary
Fig. 4A). A few days later, the peak of online queries for “taste
loss” and “smell loss” is synchronized with the report of smell and
taste changes (Supplementary Fig. 4B). One week later, queries
for shortness of breath preceded the peak of CCRU admissions
(Supplementary Fig. 4C). Collectively, these results indicate a
significant fraction of French COVID-19 patients followed the
same symptom time course, experiencing initial symptoms at the
very start of the lockdown, which might be representative of
a peak of infection a few days before the lockdown. This is
consistent with the ultimate goal of the lockdown, which was to
decrease the number of new infections following implementation.
Thus, the period immediately prior to lockdown represents the
expected peak of new infections. In France, a large population
may have been infected two days before lockdown because that
weekend was crowded and sunny and occurred over the course of
election day. Further, there were busier train stations and
supermarkets in anticipation of a shortage of supplies during
lockdown12.
These data suggest that the short-term efficacy of a lockdown
could be monitored by tracking changes in smell and taste in the
population. To assess whether such a prediction might generalize
to other countries, we performed parallel analyses with data from
Italy and the UK, where the lockdown measures were established
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Fig. 1 Changes in smell and taste as indicators of overwhelmed healthcare systems: geographic and time-related approaches. a French regions were
assigned a green or red status by the French government to guide local relaxation of lockdown protocols. Dots represent people self-reporting smell and
taste changes in a web-based survey. Base map is from OpenStreetMap and OpenStreetMap Foundation. b The number of COVID-19-related CCRU
admissions (as of May 11, 2020) correlated with the number of self-reported chemosensory changes (between March 1 and May 11, 2020, total n= 3832).
Green dots correspond to regions with a post-lockdown level labeled green, and red triangles indicate regions considered red. Values are standardized
based on the number of inhabitants (inhab.) for each regions. The two red triangles with CCRU admissions >5 are Alsace and Ile de France. The gray band
represent the confidence interval of the linear smooth (formula ‘y ~ x’) R and p represent value of the test for association between paired samples, using one
of Pearson’s product moment correlation coefficient, without correction for multiple comparisons. c Colored bar represent the value of computed
correlation coefficients (confidence intervals are depicted as thin black bars) between the number of CCRU admissions per area and i) the number of
people reporting smell and taste changes (n= 3832, blue), and ii) the governmental indicator (Gov. indicator), ratio of ER consults for COVID-19 (orange).
Analyses were done both at the level of metropolitan regions (Reg) and departments (Dep). d Temporal relationships in France between smell/taste
change symptom onset (blue solid line, n= 1476), the governmental indicator (orange dashed line), and COVID-19 cases in CCRUs (gray bars) around the
lockdown period (vertical dashed line). Data are 7-day running averages, normalized to the day with the highest value.
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with different levels of severity (see Fig. 2). We monitored the
dynamics of confirmed COVID-19 cases, self-reported first
symptoms, and self-reported taste and smell changes, and
compared them as a function of the governmental stringency
index. Immediately after lockdown, we found that the two
countries with the higher stringency index experienced a more
rapid decrease in both self-reported smell and taste changes and
COVID-19 symptoms. Further, as expected, the evolution of
confirmed COVID-19 cases differs according to the stringency
index. The governments of Italy and France rapidly increased
their stringency index, which led to a sharp decrease in COVID-
19 symptoms and cases. In contrast, in the UK, the number of
people in the UK reporting symptoms showed a slower decrease,
presumably due to a less severe lockdown policy, and the number
of confirmed cases remained high during the observation
window. In each country, self-reported smell and taste changes
can be regarded as a useful metric to predict the dynamics of
confirmed COVID-19 cases. That is, when the number of new
onsets of chemosensory changes decreases sharply (France and
Italy), the number of confirmed COVID-19 cases also decreases,
albeit with a lag of two weeks. On the contrary, a slow decrease in
the number of new onset chemosensory changes is associated
with a plateau of confirmed cases (UK).
Discussion
The present analyses reveal a strong spatial and temporal rela-
tionships between self-reported smell and taste changes and
multiple indices of health care system stress, such as admissions
to CCRUs. This is consistent with cumulative evidence showing a
high prevalence of chemosensory alterations in patients affected
by COVID-19 in Europe (France8,14, Italy9, UK2,15,16). Partici-
pants endorsed smell and taste changes only 3-4 days after their
first symptoms. Such early chemosensory estimators may repre-
sent a cost-effective and easy way to implement alternative sur-
veillance methods to large-scale virology tests, which are difficult
to perform, costly, and time-consuming, especially during a
pandemic.
A prominent question raised by these findings is whether the
smell and taste changes observed in our study are solely related to
COVID-19 or whether they can be explained by other temporal
patterns, like seasonal illnesses or allergies. To the best of our
knowledge, there are no existing studies that have explored the
dynamics of sudden anosmia (as in COVID-19) throughout the
year in France. Relationship between olfactory disturbances and
seasons have been reported in Korea, Germany or US with a
moderate increase of anosmia prevalence in spring17–19.










































Fig. 2 Evolution of COVID-19 indicators before and after the lockdown in France, Italy and the UK. The daily proportion of first symptoms is shown as a
violet line (France, n= 4720, Italy, n= 1241, UK, n= 750). The daily proportion of smell/taste changes is shown as a blue line (France, n= 1487, Italy, n=
264, UK, n= 263). The daily proportion of COVID-19 confirmed cases from the European Centre for Disease Prevention and Control (ECDC) is shown as a
red dashed line. Each panel shows both raw data (thin line) and the corresponding 7-day running average (thick line). The government response stringency
index is shown as the background color.
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overlap, the amplitude of reported changes (either due to allergy
or viral affection) were very limited compared to the present
report. To further rule out the possibility, we examined whether
the annual peak of allergies in France could explain the peak of
smell and taste changes observed here. In analyzing existing
French governmental data, we found that the annual peak of
allergies in France occurred around week 30 (beginning of
summer), multiple weeks after the observation window of the
present study (from week 5 to week 20, Supplementary Fig. 3).
Further, the French national aerobiological surveillance network
(RNSA, https://pollens.fr), which follows pollen concentration in
the atmosphere, has also indicated the first week of lockdown was
very low risk for seasonal allergies. In addition, when considering
Google Trends data, we did not observe any similar peaks in
queries for smell/taste loss in the corresponding time period in
previous years. Finally, a comparative study in Israel20 showed
that in COVID-19 suspected patient the frequency of smell
change is almost ten time higher in a COVID-19 positive patients
(68%) than in COVID-19 negative (8%). Considering that most
of the participants of the present study are diagnosed with
COVID-19 and that their description of a sudden loss of smell/
taste is consistent with the now typical presentation of COVID-19
symptoms, it is highly probable that COVID-19 infection is the
main reason of their smell and taste change. Collectively, these
data suggest the peak of smell and taste changes studied here are
more consistent with sudden COVID-19 viral infections rather
than an artifact due to seasonal illnesses.
The time lag between the onset of COVID-19-related symp-
toms and their declaration by the respondents of our study also
deserves comment. Although immediate reporting of symptoms
would have been ideal, such reporting is not possible within the
context of the sudden first wave of a new viral pandemic. A
similar time lag has been observed in other large-scale studies
focusing on olfaction and COVID-1921. Indeed, this time lag is
inevitable given the preparation time required for scientists and
clinicians design and launch such a survey, with appropriate
ethics approval, once anosmia and ageusia began to emerge as
cardinal symptoms of COVID-19. The vast majority of partici-
pants completed the survey between April 10th and April 19th,
2020, and most of them declared a date of onset of their symp-
toms roughly a month earlier (although a small fraction of par-
ticipants did indicate onset prior to 2020). A possible
consequence of a time lag between survey completion and the
effective date of symptom onset is that subjects’ statements may
have been influenced by major societal events such as the lock-
down decision, potentially creating some recall bias. To examine
whether the date of a major event like the lockdown might bias
dates of reported smell and taste loss, we explored narrative
descriptions provided by our participants. By analyzing responses
to the optional open-ended question “Please describe the pro-
gression or order you noticed your symptoms”, we observed that,
for France, a mere 11 of 3705 people (who have filled the optional
question) used the term “confinement” (“lockdown”) in their
description of the onset date. Separately, another factor that
mitigates concerns about a potential recall bias is the stable nature
of participant’s statements, regardless of their date of completion.
That is, logic suggests, the longer the time between the onset date
of smell and taste loss and the reporting date, the greater the
recall bias should be. However, our data clearly show that
regardless of the date of completion, the onset date falls within
the same period (Supplementary Fig. 1). Finally, other evidence
against a potential recall bias comes from Google Trends data.
Analyzing real-time Google queries in March, we observed a very
particular trend in France (Supplementary Fig. 4). We first
observed a peak of queries for terms associated with early
COVID-19 symptoms (fever, cough, aches) synchronized with
the declared onset of the first symptoms in the survey (around
March 18th). A few days later, a peak of online queries for “taste
loss” and “smell loss” was seen, and this was synchronized with
the date reported of smell and taste changes in our survey. The
striking concurrence between Google queries and reports in our
survey argues against the idea that a recall bias could be driving
the effects described here.
Another important factor to consider in our survey is the way
the press and media might have influenced our findings. Indeed,
when the survey was launched, smell and taste changes were
reported as symptoms of COVID-19 in the national and local
media, which might have influenced respondents to remind
themselves of such symptoms and to then report these changes
on the survey. Such an emphasis on smell and taste loss would
have biased attempts to explore the prevalence of chemosensory
deficits in COVID-19. However, the primary aim of the present
investigation was not to focus on the prevalence of anosmia and
ageusia with COVID-19, but rather to explore use of reported
smell and taste loss as indicators of COVID-19 pandemic. Still,
the media coverage of our survey could also have biased the
selection of participants geographically, as some French regions
received more media coverage than others. However, as reported
above, there was no correlation between the number of partici-
pants in a given region and the intensity of media and press
coverage for the survey in that same region. Finally, when par-
ticipants were asked to describe the chronology of their symp-
toms, they did not refer to the media coverage as a prominent
element influencing their awareness of their smell/taste changes.
While this does not exclude an implicit and non-verbalized bias
due to media coverage, this pattern suggests a genuine report of
symptoms with a high occurrence of COVID symptoms just after
the lockdown.
An interesting question raised by our findings is what impact
they might have on government strategies in a pandemic. Fol-
lowing lockdown, the rapid decrease of self-reported changes in
smell and taste in France may be representative of the effective-
ness of this decision in reducing infection rates. Similarly, data
from Italian participants show highly similar patterns, but with a
one-week difference compared to the French data. This might
reflect highly similar responses by the Italian and French gov-
ernments. Conversely, the prevalence of chemosensory changes in
the UK shows a more gradual decrease. The UK government
began with advice to avoid pubs, clubs and theaters, and to work
from home from March 16, with restrictions around March 18.
However, a lockdown was not declared until March 23, and this
was less stringent than those in France or Italy. Notably, new
COVID-19 cases in the UK showed a plateau phase which is not
observed in either France or Italy. Accordingly, we conclude that
collecting online information about changes in smell and taste
from residents (even retrospectively) may be a valuable metric of
the effectiveness of reopening strategies related to the COVID-19
pandemic.
Practically, in areas where smell and taste changes are notable
COVID-19 symptoms, the proportion of individuals who self-
report changes in their ability to smell or taste might be an early
indicator of subsequent demand for healthcare. If confirmed,
continuous monitoring of changes in smell and taste perception
would then be a highly cost-effective, minimally invasive, and
reliable way to track future COVID-19 outbreaks. When used this
way, we caution that particular attention must be paid to
potential selection bias. That is, self-report studies online can be
impacted by multiple selection biases, including socioeconomic
status, fluency with technology and willingness and interest in
participating in scientific research. When considering the present
data, at least 3 parameters may contribute to a selection bias in
our sample: (1) the age, (2) the gender of the participants, and (3)
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the format and the advertising of the survey. Regarding partici-
pant’ age, our study cohort (mean 40.7 years, sd= 12.4)) was
quite similar to the French population mean (41.1 years,
according to INSEE, https://www.insee.fr/fr/statistiques/
1893198); however, we did only include individuals over 18 due
to issues of consent, and administrative reasons, and seniors were
also less represented. For gender, our sample contained a greater
proportion of women (67%) compared to men, which might
influence the results. However, additional analysis showed no
differences in peaks of smell/taste changes across age or gender,
minimizing concerns that such selection biases may have influ-
enced present results (See Supplementary Fig. 2). We also tested
the potential selection bias due to format and the advertising of
the survey, by comparing the GCCR dataset with an independent
second study performed on French residents (see “Methods”
section). Remarkably we observed highly similar results across
studies where advertising, inclusion criteria, and survey format
were different.
Based on the present findings, we highlight the paramount
importance and robustness of associations between smell/taste
changes and COVID-19 and we strongly endorse the need for
additional large-scale validation studies to assess the causality
between the observed association between smell/taste changes and
indicators of the COVID-19 pandemic. This could be achieved by
setting up a simplified interface where selection biases are controlled
for (age, gender, motivation, media coverage, socioeconomic level,
etc.) through both traditional and online media—and whereby real
time information about changes in smell and taste in the general
population may be available to decision-makers. Subjects’ partici-
pation in the questionnaire and the reliability of the answers should
also be considered. In particular, if a participant knows how their
answers may influence enforcement of lockdown, their answers
might become less truthful. This motivation can be expressed
through different forms of behavior. Whereas some individuals may
tend to provide statements that minimize their symptoms in order
to avoid strict containment measures, others will maximize their
declaration to maintain the lockdown, or will provide honest
answers in order to participate in the collective effort to better
understand the COVID-19 pandemic. These motivational factors
are a recurrent risk in online studies and different strategies should
be held to control for them in future predictive studies. Based on the
above, a large implementation of the study of smell and taste
changes in institutional models should allow for monitoring of
COVID-19 spread. This might be especially relevant in in areas in
which testing proves difficult or delayed and for future outbreaks
that may overlap with other seasonal viral diseases which share
many of the symptoms (fever, cough etc.) but whose treatment or
prevention (vaccination) are less demanding in terms of critical care
than COVID-19. We advocate that self-report surveys should be
used to enhance other strategies such as large-scale PCR tests and
COVID-19 symptom assessments (including anosmia and ageusia)
in primary/secondary care.
In summary, we propose that an increase in the incidence of
sudden smell and taste change in the general population may be
used as a valuable minimally invasive indicator of coronavirus
spread in the population. To formally test the temporal rela-
tionship between chemosensory changes and spread of the dis-
ease, we recommend that a large-scale causal study in different
countries be conducted on real-time monitoring of self-reported
changes in the ability to smell or taste. Such a prospective study
will allow for the creation of statistical models that can assist in
prediction of future hospital admissions for COVID-19. Further,
it could also help decision-makers take important measures at the
local level, either in catching new outbreaks sooner, or in guiding
the relaxation of local lockdowns, given the strong impact of
lockdown on economic and social activities.
Methods
Online survey. This study is mainly based on data from the Global Consortium for
Chemosensory Research survey (GCCR, https://gcchemosensr.org/) – a global,
crowd-sourced online study deployed in 30+ languages22. The data analyzed here
were collected from April 7 to May 14, 2020. The protocol complies with the
revised Declaration of Helsinki and was approved as an exempt study by the Office
for Research Protections at The Pennsylvania Study University (Penn State) in the
U.S.A. (STUDY00014904; PI Hayes).
Participants in the GCCR questionnaire were recruited by word of mouth, as
well as through social and traditional media (flyers, social media, television, radio)
during the COVID-19 pandemic. It was well covered by the French press, as over
70 articles mentioned the project, at both the regional and national level (see
Supplementary Table 3). Respondents received no monetary incentive for their
participation. Inclusion criteria were as follows. (i) Questionnaire completion was
allowed only to participants who indicated they had suffered from a respiratory
disease in the past two weeks, whether they noticed a change in their taste/smell or
not. (ii) Participants aged 18 years old or younger were excluded.
For the analyses conducted in this article, only individuals reporting a change in
smell and/or taste perception were included, based on the question “Have you had
any of the following symptoms with your recent respiratory illness or diagnosis?”.
Moreover, to exclude unreliable entries, participants must have reported a
quantitative decrease of at least 5 on a 0-to-100 rating scale between their ability to
smell and/or taste before and during their recent respiratory illness or diagnosis.
Therefore, Due to this inclusion criteria, “smell/taste change” is equivalent to a
quantitative decrease of participant ability to smell and/or taste. We then extracted
individuals from the full dataset who reported living in France, Italy or the UK. As
the country of residence was completed as a text entry, we allowed for typical
variations (e.g., “United Kingdom” or “UK”), spelling mistakes, use of different
languages (e.g., “Italie” or “Italia”), as well as subdivisions (e.g., “Scotland”) and
major cities (“Paris”). Metropolitan France was split into 13 so-called “regions” in
2016. However, we considered the former system where France was split into 22
regions here, since the organization of the health system mostly remains based on
the structure built before 2016. An alternative, finer granularity, splits metropolitan
France into 96 so-called “departments.” To retrieve the French department and
region of the participants, we used the city of residence they reported in the
questionnaire and combined them with the French public website (data.gouv.fr,
after a semi-manual correction of spelling). Participants came from all
metropolitan departments but three (Mayenne, Creuse, Cantal). Consequently, the
number of responses analyzed in France was between n= 1476 and 4720
depending on the analysis conducted (i.e., on whether the information of interest
was present or missing and the date range of analysis, see Supplementary Table 1
for details). For comparison, between 264 to 1241 participants from Italy and
between 243 to 750 participants from the UK were included. Most participants
were women (FR:66.38%, IT:69.3%, UK:76.0%), and the mean age was around 40
[FR= 40.7 (sd= 12.4), IT= 41.1 (sd= 11.4), UK= 41.09 (sd= 12.1)]. In the
French data, a total of 15% of individuals tested positive for COVID-19 (lab result)
and 44% were diagnosed clinically by a medical professional from their symptoms.
The remaining 41% were not diagnosed for COVID-19 but declared a change in
perception of either smell or taste. The number of participants was normalized by
region, by using the number of inhabitants in each region as estimated by the
French public statistics office, INSEE. Finally, the time of onset of smell and taste
change was assessed via responses to several optional open-ended questions. These
included: “Please describe the progression or order you noticed your symptoms”
and the time of onset of recent disease by the question: “At what date did you first
notice symptoms of your recent respiratory illness? Provide your best guess or leave
blank if you do not remember.”
Complementary and independent French Survey. The data of another online
survey were used to evaluate the robustness of the temporal evolution of smell and
taste changes. This survey was conducted in the French population between April 8
and May 8, 2020 and aimed at characterizing chemosensory disorders in people
with and without COVID-19, as well as their consequences on quality of life. The
data of 950 respondents were eligible for comparison with data from the GCCR
survey, i.e., responses where both the date of completion and the date of smell loss
onset were provided. Only responses that were complete and from people who
were responding to the questionnaire for the first time and were over age 18 were
included. This survey was approved by the CNRS ethics committee. Data collection
was strictly anonymous. The protocol complies with the revised Declaration of
Helsinki and the study was approved by the ethics committee of the Institute of
Biological Sciences of the CNRS on the 3rd of April 2020 (DPO #TRRECH-467).
All individuals provided informed consent when participating in the survey.
Online trends. Trends of online queries by French region were performed using
Google Trends, a tool returning the popularity of a search term in a specific state or
region. Google is by far the most used search engine in France (>90% of internet
searches, according to StatCounter Global Stats). We looked for the popularity of
terms (listed in Supplementary Fig. 3, using default selection of “All categories” and
“Web search”), within the timeframe of February 1, 2020 to May 10, 2020 (from
the month of the first official COVID-related death in Europe to the end of
lockdown in France). It should be noted that Google Trends does not provide the
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actual numbers of searches but rather a relative score from 0 to 100 (100 corre-
sponding to the day with the greatest number of searches during the specified time
period). To compare Google Trends scores between French regions, we trans-
formed them by computing the relative number of queries per day in the region of
interest. For example, despite a value of 100, the peak day might represent only 5%
of the total number of queries related to the topic across the timeframe of interest
(see above).
Healthcare system data. The French governmental indicator to estimate the
circulation of the virus was calculated from the ratio of consultations for suspected
COVID-19 to general consultations at the emergency room (ER) in hospitals. This
ratio corresponds to the medical diagnostic for COVID-19 suspicion (codes
CIM10: U07.1, U07.10, U07.11, U07.12, U07.14, U07.15, U04.9, B34.2, B97.2). The
definition of COVID-19 has evolved rapidly during the lockdown period but the
diagnosis is principally based on symptoms of COVID-19 considered as common
such as fever, cough, and dyspnea (difficulty breathing). To the best of our
knowledge, anosmia and ageusia were officially considered in France as putative
symptoms of COVID-19 from a letter of the Direction Générale de la Santé (April
1st) and communication of the Haut Conseil de la Santé Publique (a letter dated
April 8, published online April 15, following a letter from the CNP-ORL dated
March 20). Areas with values of the French governmental indicator higher than
10% are considered having a high virus circulation. This indicator contributes to
the assignment of a red/green label. Allergies incidence in previous years were
calculated from the ratio of consultations for Allergy to general consultations at the
emergency room (ER) in hospitals.
Data dealing with the health status across countries (number of COVID-19
cases and deaths for each day) were downloaded on May 22, 2020 from the
European Centre for Disease Prevention and Control databank (ECDC, https://
www.ecdc.europa.eu/en). Data regarding healthcare system stress in France
(hospitalizations, CCRU entries and deaths) were also downloaded on May 22
from the French Public Health website (Géodes, Santé Publique France, https://
geodes.santepubliquefrance.fr/#c=home). Here, we use the term CCRU (Critical
Care Resuscitation Unit) to translate the French hospital service of “Réanimation.”
Raw data were normalized across regions with regard to their number of
inhabitants as estimated by INSEE. The temporal evolution of the stringency of
government response was retrieved from the Oxford COVID-19 (https://www.bsg.
ox.ac.uk/research/research-projects/coronavirus-government-response-tracker).
Here, the stringency level of a country is computed according to which measures of
a list of items (e.g., school closures, cancellation of public events, international
travel controls, etc.) are undertaken. For the post-lockdown situation, the color
assigned by the French government to each department was downloaded on May
12 from the government website. Only data before May 11 (the initial lift of the
lockdown) were included in the analyses.
Statistical analyses. Statistical analyses were pre-registered at the Open Science
Framework (OSF). Data were analyzed using R software (4.0) and its standard
packages (maps, ggplot, etc.). Data were grouped at the national level (France, Italy,
UK). In France they were also grouped at the regional level (according to the
division into 22 regions in place prior to the 2016 reform). The rationale behind
this is that the healthcare system is still structured following this organization, with
University Hospitals in regional main cities serving patients of the surrounding
departments. Participants from overseas French territories were not included in the
geographical analysis because of too few data (n < 10). The relationship between (1)
GCCR responses (or online queries), and (2) public health data was determined
using parametric (e.g., Pearson correlations) statistics as allowed by the normal
distribution of the variable of interest. The association between GCCR participant
and red/green post-lockdown status was tested using Chi-square tests and Biserial
correlations. Complementary analyses not planned in the pre-registration included:
(i) the analysis using the independent French online survey (see section “Com-
plementary and independent French Survey” of the methods), (ii) the correlation
between regional media coverage and the number of responses to the online survey
per region, (iii) the correlation at the level of department, (iv) the correlation
excluding extreme points, and (v) the correlation with the government indicator.
Pre-registered statistical analyses not presented here include: (i) Mann-Kendall
trend test and Change-point Detection test to detect time series changes, and (ii)
part of the Google Trends analysis.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The authors declare that the data supporting the findings of this study are available
within the paper and its supplementary information files. (Source Data file). Source data
are provided with this paper.
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